Home
>
National Drug Code (NDC)
>
ONGLYZA
ONGLYZA - 0003-4215-41 - (SAXAGLIPTIN)
Drug Information of ONGLYZA
| Product NDC: | 0003-4215 |
| Proprietary Name: | ONGLYZA |
| Non Proprietary Name: | SAXAGLIPTIN |
| Active Ingredient(s): | 5 mg/1 & nbsp; SAXAGLIPTIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ONGLYZA
| Product NDC: | 0003-4215 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022350 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090731 |
Package Information of ONGLYZA
| Package NDC: | 0003-4215-41 |
| Package Description: | 100 TABLET, FILM COATED in 1 BLISTER PACK (0003-4215-41) |
NDC Information of ONGLYZA
| NDC Code | 0003-4215-41 |
| Proprietary Name | ONGLYZA |
| Package Description | 100 TABLET, FILM COATED in 1 BLISTER PACK (0003-4215-41) |
| Product NDC | 0003-4215 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SAXAGLIPTIN |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090731 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | SAXAGLIPTIN HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
